Learn more about whether Edwards Lifesciences Corporation or Stryker Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Medical device maker Stryker Corporation (SYK) benefits from more procedures, sales, and acquisitions.

Medical technology company Stryker (NYSE:SYK) reported in Q4 CY2024, with sales up 10.7% year on year to $6.44 billion. Its ...

What Happened: Pierce, Group President at Stryker, made a strategic move by exercising stock options for 9,455 shares of SYK as detailed in a Form 4 filing on Thursday with the U.S. Securities and ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

Q4 2024 Earnings Call Transcript January 28, 2025 Stryker Corporation beats earnings expectations. Reported EPS is $4.01, ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

Regarding its outlook, Stryker logged expects organic sales growth of 8% to 9% for 2025, and adjusted earnings of $13.45 to $13.70 a share, as it sees sustained levels of procedural volumes and strong ...